相关临床试验
9
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
已完成
9
100.0%
暂无批准数据
- Microneedle technology is revolutionizing drug delivery by offering a minimally invasive alternative to traditional injection methods, with applications spanning vaccines, biologics, and gene therapies. - The technology shows particular promise for COVID-19 vaccine delivery and cancer vaccine applications, while also advancing diagnostic capabilities through microneedle-based testing platforms. - Regulatory bodies including the FDA and WHO are developing new guidance frameworks for microneedle device classification and quality standards to support the growing field. - Industry leaders are focusing on innovative fabrication techniques and novel materials to enhance therapeutic outcomes, improve patient compliance, and enable personalized medicine approaches.
- 3D printing technology has emerged as a transformative approach for manufacturing microneedles, offering superior precision, cost-effectiveness, and design flexibility compared to conventional fabrication methods. - Multiple 3D printing techniques including FDM, SLA, DLP, and CLIP enable the production of various microneedle types with customizable geometries and enhanced drug loading capabilities. - Recent applications demonstrate successful deployment of 3D-printed microneedles for treating skin conditions, delivering insulin, extracting biological fluids, and enabling personalized medicine approaches. - Despite promising advances, challenges remain in scaling production, ensuring material biocompatibility, and achieving consistent pharmacokinetics for clinical translation.
